Přehled publikací v časopisech s impaktovaným faktorem publikovaných v letech 2005 až 2007 (Impaktovaný faktor odpovídá roku publikace)

Původní projekty:

Reischig T., Jindra P, Hes O., Švecová M., Klaboch J., Třeška V. Valacyclovir Prophylaxis vs.
Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease after Renal Transplantation. Am J Transplant 2008, 8: 69-77. Epub Oct 31 2007, doi:10.1111/j.1600-6143.2007.02031.x (Impact Factor = 6.84)

Opatrna S, Sefrna F. Development of peritoneal dialysis in the context of changes in public health after the post-communist transition: the Czech experience. Perit Dial Int 2007, 27: 196-202 (Impact Factor = 2.37)

Richtrova P, Opatrny K Jr, Vit L, Sefrna F, Perlik R: The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters. Nephrol Dial Transplant 2007; 22:2978-84. (Impact Factor = 3,154)

Opatrny K Jr, Richtrova P, Polanska K, Wirth J, Sefrna F, Brandl M, Falkenhagen D. Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs. 2007; 31: 200-7. (Impact Factor 1,903)

Reischig T., Jindra P., Mares J., Cechura M., Svecova M, Hes O., Opatrny K. Jr., Treska V. Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection. Transplantation 2005, 79: 317-324. (Impact Factor = 3.61)

Reischig T., Opatrny K. Jr., Treska V, Mares J., Jindra P., Svecova M. Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk risk renal transplant recipients. Kidney Blood Press Res 2005, 28: 218-225. (Impact Factor = 1.04)

Opatrna S, Klaboch J, Opatrny K Jr, Holubec L, Tomsu M, Sefrna F, Topolcan O. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int. 2005, 25: 470-472. (Impact Factor = 1.056)

Zemanova P, Opatrny Jr K, Vit L, Sefrna F. Tissue factor, its inhibitor, and the thrombogenecity of two new synthetic membranes. Artif Organs 2005, 29: 651-657. (Impact Factor = 1.496)

Reischig T., Jindra P., Svecova M., Kormunda S., Opatrny K. Jr, Treska V. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. J Clin Virol 2006, 36: 146-151. (Impact Factor = 2.62)

Eiselt J, Racek J, Opatrny Jr K, Trefil L, Stehlik P. The Effect of Intravenous Iron on Oxidative Stress in Hemodialysis Patients at Various Levels of Vitamin C. Blood Purif, 2006, 24(5-6): 531-537. (Impact Factor = 1.789)

Polanská K, Opatrný Jr. K, Rokyta Jr. R, Kroužecký A, Vit L, Kasal E. The effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF. Renal Failure 2006; 28:107-118. (Impact Factor = 0.355)

Ve spolupráci s dalšími pracovišti:

Ferda J, Hora M, Hes O, Reischig T, Kreuzberg B, Mirka H, Ferdova E, Ohlidalova K, Baxa J, Urge T. Computed tomography of renal cell carcinoma in patients with terminal renal impairment. Eur J Radiol 2007, 63: 295-301. (Impact Factor = 1.88)

Racek J, Kralova H, Trefil L, Rajdl D, Eiselt J. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract 2006;103(4):c162-72. (Impact Factor = 0.878)

Reiterova J, Merta M, Stekrova J, Cabartova Z, Cibulka R, Maixnerova D, Rysava R, Rihova Z, Tesar V, Motan J. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease Kidney Blood Press Res. 2006;29(3):182-8. (Impact Factor = 2.41)